New Reckitt Plant Boosts Production of Popular MedicineNew Reckitt Plant Boosts Production of Popular Medicine

With cold and flu season arriving earlier in the year, demand for decongestant medication is growing — a trend that prompted Reckitt Benckiser Group to acquire a pharmaceutical site in Wilson, NC, for the production of Mucinex tablets and liquids.

The company is investing $200 million in the site, which will supply a more resilient supply chain in its largest market. The facility is approximately 310,000 square feet and will be Reckitt’s biggest OTC manufacturing facility in the US, creating close to 300 jobs. In addition to factory jobs, the site will support local jobs in construction, engineering, and transportation to help distribute the company’s products across the country.

New Reckitt Benckiser Mucinex plant in North Carolina. Reckitt Benckiser

According to Reckitt, the site is being retooled from packaging for pharmacy to OTC presentation, integrating equipment capable of producing not only bottle packaging but blister packaging solutions with cartoning capabilities. Reckitt will also integrate liquid packaging solutions that include nasal and spray applications.

In addition to manufacturing a range of tablets, the facility will produce Mucinex Mighty Chews. Eventually, it will have capabilities to support additional products, including Move Free and Biofreeze.